Literature DB >> 8726089

QT interval and QT dispersion in multiple system atrophy (Shy-Drager syndrome).

D Frongillo1, F Stocchi, F A Delfino, L Calò, L Bramante, F Antonucci, D De Nardo, S Ruggleri, D Cannata.   

Abstract

To evaluate the influence of autonomic function on the QT interval and QT dispersion, 18 patients (10 males and 8 females; mean age 61 +/- 9 years) with multiple system atrophy (MSA, Shy-Drager syndrome) were studied. Cardiovascular tests were performed to assess the degree of autonomic dysfunction. The QT interval, corrected QT (QTc), QT dispersion (QTd), corrected and adjusted QTd were calculated from a standard 12-lead electrocardiogram. Fifteen healthy subjects matched for sex and age were studied as controls. Nine MSA patients showed severe autonomic dysfunction with orthostatic hypotension. In the remaining patients definite autonomic impairment was found. No statistically significant difference was found in QTd and only a trend towards higher values of maximal QTc was found in patients compared with controls. QTc prolongation, defined as greater than the mean +/- 2 SD of the controls, was detected only in three out of the 18 MSA patients (17%). No correlation was found between the severity of autonomic impairment and repolarization parameters. Our data suggest that chronic autonomic impairment in patients with MSA does not significantly affect ventricular repolarization and ventricular dispersion.

Entities:  

Mesh:

Year:  1996        PMID: 8726089     DOI: 10.1007/BF02291225

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  22 in total

1.  Sympathetic and vagal influences on rate-dependent changes of QT interval in healthy subjects.

Authors:  R Cappato; P Alboni; P Pedroni; G Gilli; G E Antonioli
Journal:  Am J Cardiol       Date:  1991-11-01       Impact factor: 2.778

2.  Adrenergic effects of the QT interval of the electrocardiogram.

Authors:  J A Abildskov
Journal:  Am Heart J       Date:  1976-08       Impact factor: 4.749

3.  Degenerative diseases of the nervous system associated with autonomic failure.

Authors:  R Bannister; D R Oppenheimer
Journal:  Brain       Date:  1972       Impact factor: 13.501

4.  Does abnormal QT interval prolongation reflect autonomic dysfunction in diabetic patients? QTc interval measure versus standardized tests in diabetic autonomic neuropathy.

Authors:  M Veglio; A Chinaglia; M Borra; P C Perin
Journal:  Diabet Med       Date:  1995-04       Impact factor: 4.359

5.  Influence of the autonomic nervous system on the Q-T interval in man.

Authors:  K F Browne; D P Zipes; J J Heger; E N Prystowsky
Journal:  Am J Cardiol       Date:  1982-11       Impact factor: 2.778

6.  Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death?

Authors:  F Bellavere; M Ferri; L Guarini; G Bax; A Piccoli; C Cardone; D Fedele
Journal:  Br Heart J       Date:  1988-03

7.  The value of cardiovascular autonomic function tests: 10 years experience in diabetes.

Authors:  D J Ewing; C N Martyn; R J Young; B F Clarke
Journal:  Diabetes Care       Date:  1985 Sep-Oct       Impact factor: 19.112

8.  Pharmacologic distinction of different orthostatic hypotension syndromes.

Authors:  R J Polinsky; I J Kopin; M H Ebert; V Weise
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

9.  Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients.

Authors:  D J Ewing; O Boland; J M Neilson; C G Cho; B F Clarke
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

10.  Influence of heart rate and inhibition of autonomic tone on the QT interval.

Authors:  S Ahnve; H Vallin
Journal:  Circulation       Date:  1982-03       Impact factor: 29.690

View more
  1 in total

1.  Age and Gender Differences in Cardiovascular Autonomic Failure in the Transgenic PLP-syn Mouse, a Model of Multiple System Atrophy.

Authors:  Marc Kermorgant; Pierre-Olivier Fernagut; Wassilios G Meissner; Dina N Arvanitis; Du N'Guyen; Jean-Michel Senard; Anne Pavy-Le Traon
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.